Heart failure in thyrotoxicosis, an approach to management.
Choudhury
R P
RP
Section on Clinical Pharmacology, Imperial College School of Medicine, Hammersmith Hospital, London.
MacDermot
J
J
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000638:Amiodarone / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D002231:Carbimazole / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D013971:Thyrotoxicosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D002316:Cardiotonic Agents; D004077:Digoxin; D002231:Carbimazole; D000638:Amiodarone